As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
We spend a lot of time in the clinic trying to optimize exercise and nutrition, he said
During the study period, a total of 7,927,000 reports were retrieved from the FAERS database
If the solution looks the same as it did on day one, it is likely still good
Staying well-hydrated supports circulation and metabolic function
As I have an aggressive diet plan alongside this, I saw results within a couple of weeks